Build vs Buy a Digital Underwriting Platform in 2026

Every insurtech CTO eventually arrives at the same fork in the road: commit a multi-year engineering budget to constructing an underwriting stack from scratch, or license a platform and redirect that capital toward distribution and risk differentiation. The digital underwriting platform build vs buy question has grown sharper in 2026 because the underlying components, rules engines, document ingestion, vitals capture, third-party data orchestration, are now available as composable services rather than monolithic systems. That shift changes the math. The decision is no longer build everything or buy everything; it is choosing which layers genuinely differentiate your book of business and which are commodity infrastructure that a vendor can run more cheaply than your own team.

The global insurance platform market is projected to grow from $116.16 billion in 2025 to $207.52 billion by 2030, with AI and analytics carrying the fastest growth rate and 45 percent of insurance firms already running AI-driven underwriting or claims tooling., MarketsandMarkets, Insurance Platform Market Report (2025)

Framing the digital underwriting platform build vs buy decision

The classic framing pits control against speed. Building grants full ownership of intellectual property, data models, and workflow design. Buying compresses time-to-market and shifts maintenance burden onto a vendor. Both framings are correct and both are incomplete, because the real cost of an in-house underwriting system is rarely the initial build. It is the decade of maintenance, regulatory change, and integration debt that follows.

Forrester has estimated that roughly 80 percent of enterprise IT spending goes to maintenance rather than new development. For an underwriting platform, that ratio is punishing: rules change with every regulatory update, reinsurance treaty, and product launch. A system that takes 18 months to build can consume far more engineering capacity in years two through five than it did at launch. Decerto's 2025 CTO guidance on insurance software makes a similar point, noting that custom builds carry multi-year timelines and ongoing cost that often outlast the original sponsoring executive.

There is a counterweight. Industry surveys cited across 2025 build-versus-buy analyses report that 63 percent of insurance executives believe custom software delivers better long-term return on investment because it aligns precisely with their processes. The tension between those two data points, high maintenance drag versus tight process fit, is exactly where the decision lives.

Cost, time, and maintenance compared

The table below summarizes how the two paths, plus the increasingly common hybrid, compare across the dimensions a CTO actually defends in a board meeting.

| Dimension | Build in-house | Buy / license platform | Hybrid (buy core, build differentiators) | |---|---|---|---| | Time to market | 12-36 months to first policy | Weeks to a few months | 3-9 months | | Upfront engineering cost | High capital outlay, large team | Low, mostly integration | Moderate | | In-house underwriting system cost over 5 years | Build cost plus heavy maintenance | Subscription, may rise 10-20% at renewal | Subscription plus focused build | | Maintenance ownership | Your team, indefinitely | Vendor handles upgrades | Shared by layer | | IP and differentiation | Full ownership | Limited to configuration | Own the parts that matter | | Regulatory update burden | Internal backlog | Vendor roadmap | Split | | Scaling risk | You absorb it | Vendor absorbs it | Mostly vendor | | Talent dependency | High, key-person risk | Low | Moderate |

A few patterns emerge from how teams weigh these rows:

• Time-to-market in insurtech is usually the deciding variable for early-stage carriers and MGAs that need to validate a product before capital runs out. A 24-month build can outlast the runway it was meant to serve.
• In-house underwriting system cost is consistently underestimated because teams price the build, not the operate-and-evolve phase that dominates total cost of ownership.
• Subscription pricing is not static. Gartner has observed enterprise SaaS renewal increases of 10 to 20 percent or more, so buy-side models should assume escalation rather than a flat line.
• The fastest-moving teams treat data ingestion, vitals capture, and rules execution as commodity layers to license, while reserving in-house engineering for proprietary risk scoring and pricing logic.

Industry applications and where the line gets drawn

The build-versus-buy choice rarely applies uniformly across a platform. It applies layer by layer. The practical question is which modules carry competitive advantage and which are table stakes.

Carriers and MGAs

For carriers and managing general agents, the differentiator is almost always pricing and risk selection, not the plumbing. These teams increasingly buy the underwriting workbench, policy admin connectors, and document pipeline, then build or fine-tune the models that decide who gets offered what. Buying the chassis and building the engine lets a small actuarial-engineering team punch above its headcount.

Insurtech startups

For an early-stage insurtech, the underwriting automation roadmap is a survival document. Speed compounds: every month spent building infrastructure is a month not spent acquiring policyholders or refining loss ratios. Most viable startups now begin on licensed platforms and only internalize components once volume justifies the operating cost. The hybrid path lets them ship in a quarter rather than a fiscal year.

BPO and underwriting service providers

Business process outsourcers and underwriting-as-a-service vendors face a different calculus. Their margin lives in per-file processing cost, so automation of repetitive capture and triage steps pays back quickly. Buying proven automation, including real-time vitals capture and structured health data integration, lowers the cost per file without forcing them to staff a permanent platform engineering team.

Current research and evidence

The evidence base in 2025 points consistently toward composition over construction. Gartner has forecast that 85 percent of IT strategies will be cloud-first and that more than 70 percent of enterprises will run hybrid infrastructure, with global cloud spending surpassing $700 billion in 2025 and SaaS approaching $300 billion. That macro shift makes a fully self-hosted, self-built underwriting stack an increasingly unusual choice rather than a default.

The TCO research complicates the simple buy is cheaper narrative. Multiple 2025 total-cost-of-ownership analyses note that subscription models tend to win on a three-to-four-year horizon, after which heavy, stable, high-utilization workloads can become cheaper to run in-house. Underwriting platforms rarely fit the stable-workload profile, though, because regulatory and product change keeps the maintenance meter running. That dynamic favors buying or hybridizing the volatile, rules-heavy layers while reserving in-house ownership for stable proprietary models.

Vendor and analyst commentary converges on a third path. Federato and BriteCore both frame the core-system decision as less binary than it once was, arguing that API-driven ecosystems let teams assemble best-of-breed components. The practical implication for underwriting platform vendors and their buyers is that integration quality, not raw feature count, has become the differentiator. A platform that exposes clean APIs for risk scoring, vitals, and health data integration can be adopted incrementally, which lowers the switching risk that historically pushed teams toward building.

The future of the digital underwriting platform build vs buy decision

Three forces will reshape this decision over the next few years. First, composability will keep eroding the case for monolithic builds. As more underwriting functions ship as APIs, the question moves from build or buy a platform to which six or seven services to wire together. Second, real-time data will raise the bar on what counts as a differentiator. Static questionnaire-based underwriting is becoming commodity, while continuous and vitals-based risk signals are where pricing edges now form. Third, regulatory scrutiny of automated decisioning will increase the maintenance tax on any rules logic, which strengthens the case for letting a specialized vendor absorb that burden on commodity layers.

The likely equilibrium is not pure build or pure buy. It is a thin proprietary core of pricing and risk-selection logic surrounded by licensed, well-integrated infrastructure. CTOs who define that core narrowly, and refuse to rebuild what a vendor already runs reliably, will ship faster and spend less over a five-year horizon. The discipline is resisting the urge to build the parts that feel important but are not actually differentiating.

Frequently asked questions

Is building a digital underwriting platform ever the right choice in 2026? Yes, but narrowly. Building makes sense for the proprietary pricing and risk-selection logic that defines your competitive edge, or for incumbents with large engineering teams and very specific legacy constraints. For commodity layers such as document ingestion, vitals capture, and rules execution, licensing is almost always faster and cheaper over a five-year horizon.

Why is in-house underwriting system cost so often underestimated? Teams price the initial build but not the operate-and-evolve phase, which dominates total cost. With roughly 80 percent of IT spending going to maintenance per Forrester estimates, regulatory updates, integrations, and key-person risk compound year after year. The build is the down payment, not the full price.

How much faster is buying versus building for time-to-market? Licensed platforms typically reach a first live policy in weeks to a few months, while custom builds run 12 to 36 months. A hybrid approach, licensing the core and building only differentiators, usually lands between three and nine months.

What should a CTO evaluate first when comparing underwriting platform vendors? Integration quality and API design, not feature count. A platform that exposes clean APIs for risk scoring, vitals, and health data integration can be adopted incrementally and replaced later, which lowers switching risk and lets you keep ownership of the layers that differentiate your book.

Circadify is addressing the commodity layer of this decision with a real-time, vitals-based risk scoring API built to drop into a digital underwriting platform rather than replace one. CTOs weighing build versus buy can test the integration directly through the API docs and sandbox at circadify.com/custom-builds before committing engineering budget.